ArticlePloS one2021

Serum N-terminal telopeptide of type I collagen as a biomarker for predicting bone density loss in patients with Crohn disease.

Natsuki Ishida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.